A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

Exclusion Criteria

• •Are individuals of childbearing potential.
• •Have significant central nervous system or psychiatric disease, other than AD, that in the investigator's opinion may affect cognition or the ability to complete the study (e.g: head trauma, stroke, seizure disorder etc.,).
• •Have cardiovascular-related risk factors or history that include uncontrolled hypertension, heart failure, stroke; or liver-related abnormalities.
• •Use of moderate or strong CYP3A4 inhibitors or inducers.
• •Have participated within the last 30 days in a clinical trial involving an investigational product.
• •Participant is, in the judgment of the investigator, actively suicidal and therefore deemed to be at significant risk for suicide.